Search

Your search keyword '"Ngo, Shyuan T."' showing total 262 results

Search Constraints

Start Over You searched for: Author "Ngo, Shyuan T." Remove constraint Author: "Ngo, Shyuan T."
262 results on '"Ngo, Shyuan T."'

Search Results

1. A transient protein folding response targets aggregation in the early phase of TDP-43-mediated neurodegeneration

2. Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1

5. Polygenic risk score analysis for amyotrophic lateral sclerosis leveraging cognitive performance, educational attainment and schizophrenia

6. Impaired signaling for neuromuscular synaptic maintenance is a feature of Motor Neuron Disease

7. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

8. Characterization of the skeletal muscle arginine methylome in health and disease reveals remodeling in amyotrophic lateral sclerosis

9. Variation in Resting Metabolic Rate Affects Identification of Metabolic Change in Geographically Distinct Cohorts of Patients With ALS

11. Characterization of the skeletal muscle arginine methylome in health and disease reveals remodeling in amyotrophic lateral sclerosis

13. Skeletal-Muscle Metabolic Reprogramming in ALS-SOD1G93A Mice Predates Disease Onset and Is A Promising Therapeutic Target

14. Characterization of the skeletal muscle arginine methylome in health and disease reveals remodeling in Amyotrophic Lateral Sclerosis

18. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

19. Significant out-of-sample classification from methylation profile scoring for amyotrophic lateral sclerosis

22. Skeletal muscle in amyotrophic lateral sclerosis

23. Associations of postprandial ghrelin, liver‐expressed antimicrobial peptide 2 and leptin levels with body composition, disease progression and survival in patients with amyotrophic lateral sclerosis.

25. The Arylamine N-Acetyltransferases as Therapeutic Targets in Metabolic Diseases Associated with Mitochondrial Dysfunction

27. Skeletal muscle in amyotrophic lateral sclerosis

32. Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS

33. Patient perspectives on digital healthcare technology in care and clinical trials for motor neuron disease: an international survey

34. Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1

36. Additional file 2 of Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1

37. Additional file 1 of Impaired signaling for neuromuscular synaptic maintenance is a feature of Motor Neuron Disease

38. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

39. Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1 G93A mice

40. Lower hypothalamic volume with lower body mass index is associated with shorter survival in patients with amyotrophic lateral sclerosis.

45. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

46. Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders

47. Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders

48. Venous creatinine as a biomarker for loss of fat-free mass and disease progression in patients with Amyotrophic Lateral Sclerosis

49. Polygenic risk score analysis for amyotrophic lateral sclerosis leveraging cognitive performance, educational attainment and schizophrenia

Catalog

Books, media, physical & digital resources